|
CDC123 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.036400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.168820E-01 |
| Normal-vs-Stage2 |
4.986000E-01 |
| Normal-vs-Stage3 |
6.389600E-02 |
| Normal-vs-Stage4 |
3.475600E-03 |
| Stage1-vs-Stage2 |
5.463800E-01 |
| Stage1-vs-Stage3 |
7.557900E-03 |
| Stage1-vs-Stage4 |
1.029350E-04 |
| Stage2-vs-Stage3 |
3.555600E-02 |
| Stage2-vs-Stage4 |
6.162800E-03 |
| Stage3-vs-Stage4 |
6.602200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.647250E-01 |
| Normal-vs-AfricanAmerican |
4.111800E-01 |
| Normal-vs-Asian |
1.740430E-01 |
| Caucasian-vs-AfricanAmerican |
1.494180E-01 |
| Caucasian-vs-Asian |
1.304250E-01 |
| AfricanAmerican-vs-Asian |
2.777000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.368600E-01 |
| Normal-vs-Female |
2.381900E-02 |
| Male-vs-Female |
1.200300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.247600E-01 |
| Normal-vs-Extreme_Weight |
9.797900E-02 |
| Normal-vs-Obese |
9.510200E-01 |
| Normal-vs-Extreme_Obese |
8.126400E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.830010E-01 |
| Normal_Weight-vs-Obese |
7.863800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.498600E-01 |
| Extreme_Weight-vs-Obese |
8.592300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.063200E-01 |
| Obese-vs-Extreme_Obese |
2.260600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.189700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.104800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.443700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.199630E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.899700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.897700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.457780E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.521670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.919600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.221600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.086200E-01 |
| Normal-VS-Type2 PRCC |
9.682800E-01 |
| Normal-VS-KIRP CIMP |
3.158300E-03 |
| Normal-VS-Unclassified PRCC |
9.320600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.971200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.191700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.373200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.580800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.690600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.80910000000024E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.754800E-01 |
| Normal-vs-N1 |
5.152100E-02 |
| Normal-vs-N2 |
5.636600E-01 |
| N0-vs-N1 |
2.916200E-02 |
| N0-vs-N2 |
4.678800E-01 |
| N1-vs-N2 |
6.813400E-01 |
|
|
